SUTENT caps 50 mg 28 pce

7680575630067 CH-57563 L01EX01 07.16.1.

Reimbursement limitations:

SUTENT

Traitement de patients atteints de tumeurs stromales gastro-intestinales malignes (GIST) en cas de résistance ou …

SUTENT caps 50 mg 28 pce
SUTENT caps 50 mg 28 pce
SUTENT caps 50 mg 28 pce
1 / 3
google

Details

Product number
5756303
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
sunitinibum 50 mg ut sunitinibi malas, mannitolum, carmellosum natricum conexum, povidonum K 25, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 171, E 172 (flavum), E 172 (nigrum), Drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, E 171, pro capsula corresp. natrium 0.71 mg.

Articles (1)

Sutent 50 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/08/2024
Patient information leaflet
Français
08/08/2024
Patient information leaflet
Italien
08/08/2024
Professional SmPC
Allemand
08/08/2024
Professional SmPC
Français
08/08/2024
Professional SmPC
Italien
08/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
0.71 MG Substance HBESI

Reimbursement information

Public price
CHF 3642.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2008

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
57563
Drug name
Sutent, Hartkapseln
Galenic form
KAHA
ATC Code
L01EX01
Authorization status
Z
Dispensation category
A
First authorization
28/04/2006
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von gastrointestinalen Stromatumoren, Behandlung des Nierenzellkarzinoms, Behandlung von neuroendokrinem Pankreaskarzinom

Packaging details

Description (FR)
SUTENT caps 50 mg 28 pce
Description (DE)
SUTENT Kaps 50 mg 28 Stk
Market launch
28/04/2006
Narcotic (BTM)
No

Available generics

Sunitinib-Teva, Hartkapseln
GTIN: 7680677810015
CHF 887.35
View
Sunitinib-Teva, Hartkapseln
GTIN: 7680677810022
CHF 1758.15
View
Sunitinib-Teva, Hartkapseln
GTIN: 7680677810046
CHF 3329.50
View
Sunitinib Viatris, Hartkapseln
GTIN: 7680680940044
CHF 887.35
View
Sunitinib Viatris, Hartkapseln
GTIN: 7680680940051
CHF 1758.15
View
Sunitinib Viatris, Hartkapseln
GTIN: 7680680940068
CHF 3329.50
View
Sunitinib Zentiva, Hartkapseln
GTIN: 7680681340010
CHF 887.35
View
Sunitinib Zentiva, Hartkapseln
GTIN: 7680681340027
CHF 1758.15
View
Sunitinib Zentiva, Hartkapseln
GTIN: 7680681340034
CHF 3329.50
View

Other packaging sizes

SUTENT caps 12.5 mg 28 pce
28 KAP
GTIN: 7680575630043
View
SUTENT caps 25 mg 28 pce
28 KAP
GTIN: 7680575630050
View